Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Tim Anderson
Pharma
IRS alleges BMS dodged up to $1.38B in taxes in 2012: report
The IRS alleges Bristol Myers created an offshore subsidiary in Ireland and used it to lower its tax rate from 25% to negative 6.9% in 2012.
Arlene Weintraub
Apr 1, 2021 10:19am
AZ eyes multibillion-dollar Tagrisso sales bump after trial win
Apr 13, 2020 12:13pm
BMS nets Opdivo lung cancer win—but it still has to beat Merck
Oct 22, 2019 11:20am
BMS-Celgene integration questions? Execs aren't answering
Apr 26, 2019 11:45am
Does Bristol have a plan B if activists scuttle Celgene buy?
Mar 11, 2019 12:12pm
Can BMS rebels scuttle its Celgene buy? Analysts do the math
Mar 1, 2019 11:18am
